CLINICAL_TRIALS
trial_result
· 2026-07-16
Clinical Trial Results: Tiotropium/Salmeterol Inhalation Powder in COPD [Phase 3]
Summary
Phase 3 trial results for Tiotropium/Salmeterol inhalation powder in chronic obstructive pulmonary disease have been reported.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: TERMINATED | Results posted: 2026-07-16